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Background: Upon entering the pancreatic -cell, glucose is metabolized to ultimately induce both proliferation and the
release of insulin.
Results:miR-184 targets Argonaute2 to impact the microRNA pathway according to glucose metabolism.
Conclusion:miR-184 is a highly regulated microRNA impacting the growth and function of the -cell.
Significance: These results highlight the adaptive role of the microRNA pathway based on metabolic state.
In response to fasting or hyperglycemia, the pancreatic -cell
alters its output of secreted insulin; however, the pathways gov-
erning this adaptive response are not entirely established.
Although the precise role of microRNAs (miRNAs) is also
unclear, a recurring theme emphasizes their function in cellular
stress responses. We recently showed that miR-184, an abun-
dantmiRNA in the-cell, regulates compensatory proliferation
and secretion during insulin resistance. Consistent with previ-
ous studies showingmiR-184 suppresses insulin release, expres-
sion of this miRNA was increased in islets after fasting, demon-
strating an active role in the -cell as glucose levels lower and
the insulin demand ceases. Additionally, miR-184 was nega-
tively regulatedupon the administrationof a sucrose-richdiet in
Drosophila, demonstrating strong conservation of this pathway
through evolution. Furthermore, miR-184 and its target Argo-
naute2 remained inversely correlated as concentrations of
extracellular glucose increased, underlining a functional rela-
tionship between this miRNA and its targets. Lastly, restoration
of Argonaute2 in the presence of miR-184 rescued suppression
ofmiR-375-targeted genes, suggesting these genes act in a coor-
dinated manner during changes in the metabolic context.
Together, these results highlight the adaptive role of miR-184
according to glucosemetabolismand suggest the regulatory role
of this miRNA in energy homeostasis is highly conserved.
Our understanding of the compensatory mechanisms con-
trolling pancreatic -cell function according to changes in
extracellular glucose remains incomplete (1, 2). Upon entering
the-cell, glucose ismetabolized to ultimately induce both pro-
liferation and the release of insulin (3–5). However, the full
extent to which genes that regulate growth and secretion
respond to the molecular events that follow glycolysis, includ-
ing mitochondrial and ATP metabolism, is not completely
known. Recent studies have shown that deletion of glucokinase
(Gck) reduced-cell replication, underlining the role of glucose
as a key mitogenic factor in this cell type (6). In addition, the
BCL-2 family member BAD occupies a glucokinase-containing
complex to regulate mitochondrial respiration in the -cell in
response to glucose (7). Moreover, in response to a glucose
stimulus, quiescent-cells entered theG1 phase of the cell cycle
further emphasizing the tight association between the glyco-
lytic pathway and the mechanisms regulating -cell mass (8).
Specific cell cycle regulators and polycomb group (PcG) pro-
teins have also been shown to regulate -cell proliferation and
regeneration, indicating that many conserved and functionally
diverse factors contribute to this process (9, 10). Furthermore,
the growth rate of the -cell declines with age in both mouse
and human, indicating many regulatory mechanisms act in an
age-dependent manner (11, 12).
We recently showed that miR-184, a highly conserved and
abundant miRNA2 expressed in the -cell, regulates compen-
satory proliferation and insulin secretion during insulin resis-
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tance (13). Using both genetic and diet-induced mouse models
of obesity and insulin resistance, we observed the silencing of
miR-184 in the pancreatic islet, and upon treatment of a low
carbohydrate ketogenic diet, its expression was rescued (13).
Importantly, these results suggested thatmiRNAsmay respond
to changes in the metabolic environment of the cell including
systemic insulin sensitivity and glucose concentrations. Al-
though the precise role of the miRNA pathway remains to be
established,many studies have highlighted its regulatory role in
gene regulation during adaptive response mechanisms (14).
Under steady-state conditions, many loss-of-function mouse
models for miRNA genes exhibit subtle phenotypes that
become more pronounced upon the induction of physiologic
stresses (15). To date, the impact of changes in nutrient intake
and sensing on themiRNApathway has not been characterized.
Therefore, our main goal was to identify the extent to which
miRNAs are altered according to extracellular glucose levels
and to determine the functional relevance of their regulation.
In this study we first reinvestigated the impact of a long term
ketogenic diet on miR-184 expression in the pancreatic -cell;
as in our previous work we found that administration of this
diet to hyperglycemic ob/ob mice restored both insulin sensi-
tivity and normoglycemia (13). Furthermore, our studies also
show that reverting from a ketogenic diet back to a normal
chow restoresmiR-184 expression to normal within 24 h, illus-
trating the modulatory behavior of this one specific miRNA.
Moreover, fasting and inhibition of glycolysis both resulted in
increased levels ofmiR-184, indicating this miRNA is activated
to suppress secretion as the demand for insulin is abated.
Lastly, our observations showing the silencing of miR-184 in
response to a high sucrose diet in Drosophila suggests this
miRNA may contribute to a highly conserved mechanism
regulating energy homeostasis. Together these results iden-
tify the adaptive functional role of miR-184 according to
glucose metabolism and establish the conservation of its mod-
ulatory behavior to Drosophila.
Experimental Procedures
Generation and Maintenance of Animals—Mice were main-
tained on a 12-h light/dark cycle with ad libitum access to
regular chow food or ketogenic diet (catalog number
E15149-30, ssniff Spezialdiäten GmbH) in accordance with
requirements established by Landesamt für Gesundheit und
Soziales (Lageso). All experimental procedures were approved
under protocols G 0357/10, O 0405/09, and T 0436/08. The
totalmiR-184 knock-out (184KO),dox-184, anddox-Ago2mice
were generated and genotyped as previously described (13).
Gene Expression Array Analysis—MIN6 cells were trans-
fected with rtTA reverse transactivator along with 184-tetO
plasmids. Overexpression of miR-184 was induced by 1 g/ml
doxycycline (Sigma) at time points between 16 and 72 h in trip-
licate. Cells were harvested, and cDNA synthesis was per-
formed from total RNA using the Illumina TotalPrep RNA
Amplification kit (AMIL1791, Life Technologies) and then
hybridized using IlluminamouseWG6v2 arrays. Rawdata from
the Illumina scanner were loaded into R using the lumi package
(Illumina). Mappings to gene names and gene IDs were pro-
vided by the lumiMouseIDMapping package. Light intensities
were quantile-normalized using the lumiN function, and the
analysis focused on probes for the detection of p values 0.05
either in the transfection control or at any of the time points of
the experiment. For subsequent analyses, we focused on these
probes, discarding all others. Mappings of probes to gene IDs
were obtained from the lumiMouseAll.db package, and we
computed the differential regulation in gene expression as the
log 2-fold change in signal intensity at the different time points
compared with the transfection control. We investigated the
effect of themiR-184 induction on themiR-184 target genes as
well as on the target genes ofmiR-375,miR-182,miR-30a, and
148a/152 that are highly expressed in MIN6 cells. For each of
these fourmiRNAs, we collected groups of target genes accord-
ing to the presence of a canonical binding site in the 3-UTR,
defined as a heptamer complementary to positions 2–8 of the
miRNA, or to positions 2–7 with a ’U’ at position 1 (16). A fifth
group (which we called “no seed”) consisted of genes with no
canonical binding site for any of these miRNAs in the 3-UTR.
3-UTR sequences were downloaded from the RefSeq database
(NCBI) on January 18, 2011. For each of these groups of genes
and for each time point, we finally computed the mean log
2-fold change in gene expression upon miR-184 induction as
well as the standard error.
Gene Expression Analysis in Drosophila—Canton-s flies were
maintained at 25 °C in 12 h light:12 h dark cycles on a standard
diet (yeast, 38 g/liter; yellow cornmill, 91 g/liter; agar, 10 g/liter;
molasses, 8.7% v/v; propanoic acid (BioLab), 0.9% v/v; Tegasept
solution (Sigma; 300 g/liter in EtOH (BioLab)), 0.8% v/v). For
experimental manipulation, 3-day-old canton-s flies were
starved for 16 h and then supplemented with sucrose (2% agar
and 5% sucrose food media), and flies were collected at 0, 6, 12,
and 18 h. RNA was generated from fly heads by using TRIzol
reagent (Invitrogen). RNA was incubated with poly(A) poly-
merase (Ambion), and cDNA was synthesized using oligo-
dT primers. qRT-PCR was performed with Bio-Rad (C
1000TM Thermal cycler) real time PCR. The following primer
sequences were used in gene study:mir-184GACGGAGAAC-
TGATAAGGG; ribosomal protein 49 (rp-49), CGGTTACGG-
ATCGAACA; universal primer, GCGAGCACAGAATTAAT-
ACGAC. miRNA values were normalized with the ribosomal
protein 49 (rp-49).
Cell Culture, Biochemical Fractionation, and Antibodies—
MIN6 cells were cultured inDMEM(Invitrogen) containing 4.5
g/liter glucose supplemented with 15% v/v heat-inactivated
FCS, 50 M -mercaptoethanol, and 50 mg/ml penicillin, and
100 mg/ml streptomycin. SILAC-labeling of MIN6 cells and
LC-MS/MS-based quantitative proteomics were performed
exactly the same way as described previously (23). Antibodies
that were used throughout this work were as follow: Ago2 (Cell
Signaling C34C6), -tubulin (Sigma T6557), Rab3a (Abcam
ab3335), Nsf (BD Bioscience), Grp78 (Assay Designs StressGen
SPA-826), Slc25a22 (Sigma AV44041), Dicer (Bethyl A301–
936A), and Bcl-xL (Cell Signaling #2764). For biochemical frac-
tionation, an eight-step sucrose gradient was performed on
MIN6 cells as described previously (23). Briefly, MIN6 cells
were washed, pelleted, and resuspended in homogenization
buffer containing 5 mM HEPES, 0.5 mM EGTA, and 1 Com-
plete Protease inhibitors (RocheApplied Science) at pH 7.4 and
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later homogenized. The homogenate was spun at 3000 g for
10 min at 4 °C, and the post-nuclear supernatant was loaded
onto an 8-step discontinuous sucrose density gradient (HEPES-
buffered 0.2–2 M sucrose) and centrifuged at 55,000 rpm for 2 h
at 4 °C using an MLS50 rotor (Beckman Coulter). Mitochon-
drial subcellular fractionation was performed as described pre-
viously with minor modifications (17). Briefly, 1  107 MIN6
cells were washed, resuspended in isotonic mitochondrial
buffer (250 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM
HEPES pH 7.5), and homogenized. The lysates were spun at
500  g for 5 min to eliminate unbroken cells, and the super-
natant was centrifuged at 10,000  g for 30 min at 4 °C. The
mitochondria-enriched pellet was washed twice and resus-
pended in mitochondrial buffer for downstreamWestern blot-
ting analysis.
Transmission Electron Microscopy—Approximately 50 iso-
lated islets were fixed in 2.5% glutaraldehyde in Millonig’s
buffer (2.26% NaH2PO4 and 2.52% NaOH) for 2 h at 4 °C and
then stained in 1.0% osmium tetroxide for 1 h. After dehydra-
tion in ethanol, islets were embedded in AGAR 100 (Oxfors
Instruments Nordiska AB, Sweden), sectioned (70–90 nm
thick), placed on copper grids, and contrasted with uranyl ace-
tate and lead citrate. Imaging was performed on JEM 1230 elec-
tronmicroscope (JEOL-USA, Inc., MA), andmicrographs were
analyzed with respect to mitochondrial morphology.
Analytic Procedures—Insulin measurements from plasma
and sucrose gradient fractions were measured by radioimmu-
noassay (Millipore), blood glucose was measured as described
(18). In vivo glucose or insulin tolerance tests were performed
after a 6-h fast and injected intraperitoneally with either glu-
cose (1 g/kg bodyweight) or insulin (0.75 units/kg bodyweight),
respectively.
Statistical Analysis—All qRT-PCR results are expressed as
the mean  S.E. Comparisons between data sets with two
groups were evaluated using an unpaired Student’s t test. A p
value of0.05 was considered statistically significant. The cor-
relation plots were performed using GraphPad Prism.
Results
miR-184 Is Regulated According to Glucose Metabolism—
miR-184 is well expressed in the islets when compared with
other endocrine tissues such as pituitary, adrenal, and thyroid
and more specifically enriched in the MIN6 -cell line com-
paredwith other cell lines of exocrine pancreas (Fig. 1,A andB).
Consistent with our previous observation, long term adminis-
tration of the ketogenic diet for 75 days to C57BL/6 wild-type
mice induced 3-fold over-expression of miR-184 in their
islets (13) (Fig. 1C). In addition, after reverting wild-type mice
fed a ketogenic diet for 25 days back to normal chow,miR-184
expression was restored to normal levels in 24 h (Fig. 1D).
Moreover, returning mice to a normal chow diet also reversed
the effects on both glucose tolerance and insulin sensitivity (Fig.
1, E and F). To further test the effect of nutrient intake on the
expression of this miRNA, we next fasted C57BL/6 mice for
30 h, which lowered both glucose and insulin levels. During this
fasting phase, we observed a significant increase inmiR-184 in
isolated islets from these animals, and this increasewas normal-
ized 24 h after re-feeding the fasted mice (Fig. 1G). To test
whether circulating factors impacting energy homeostasis con-
tribute to changes in miR-184 expression, we treated MIN6
cells with either 100 nM insulin or 20 nM exendin-4 (Ex4) for
48 h and observed no changes in miRNA expression by qRT-
PCR (Fig. 1H). In line with fasting, feeding mice with a caloric-
restricted diet over a period of 25 days also resulted in an
enhanced expression ofmiR-184, whereas the levels ofmiR-375
remained unchanged in the isolated islets from these mice (Fig.
1I). Moreover, it has been previously shown that miR-184 was
silenced in both the pancreatic islets of type 2 diabetic human
subjects compared with non-diabetic controls and in Aplysia
sea snails after administration of serotonin in the central nerv-
ous system, suggesting its functional role may be conserved a
great distance (13, 19).miR-184 is also abundantly expressed in
Drosophila, a widely used model for the study of metabolism
and longevity; however, its precise functional role in this species
remains unknown (20–22). To determine whether miR-184 is
also regulated in response to metabolic stimuli in Drosophila,
we first provided a sucrose-rich diet to flies after a 16-h fasting
period. miR-184 expression significantly decreased 6 h after
initiating this diet, indicating that the silencing of this miRNA
as glucose metabolism increases is strongly conserved (Fig. 1J).
Consistent with our observations in isolated mouse islets, fast-
ing of flies also induced the expression of thismiRNA, and upon
re-feeding, its levels were normalized (Fig. 1J).
miR-184 and Ago2 Remain Inversely Correlated According to
Glucose Metabolism—To further understand the role of glu-
cose metabolism in regulating miR-184, we next inhibited gly-
colysis either by siRNA-mediated knockdown of Gck or treat-
ment of 2-deoxyglucose inMIN6 cells and observed an increase
in the expression of miR-184 (Fig. 2, A and B). Conversely,
treatment with the glucokinase activator RO-28-1675 resulted
in reduced miR-184 levels consistent with increasing glucose
metabolism (Fig. 2C). Moreover, the inverse correlation
betweenmiR-184 and its targets was also observed upon incu-
bating both MIN6 cells and isolated islets in high and low glu-
cose concentrations (Fig. 2, D–G).
Although previous studies have shown that miR-184 medi-
ates the developmental transition of the female germ line in
Drosophila as well as neural stem cell differentiation and pro-
liferation in mice, miR-184 knock-out mice (184KO) did not
display developmental or behavioral abnormalities as quanti-
fied by body weight, food intake, energy expenditure, and loco-
motor activity in comparison to littermate controls (Fig. 2,
H–K) (23, 24). To ultimately test the direct role of miR-184 in
maintaining glucose levels, we fasted 184KOmice and observed
decreased blood glucose and increased plasma insulin levels
(Fig. 2L). These results indicate thatmiR-184 can directly con-
tribute to systemic glucose levels as glucose metabolism is
reduced in the -cell. Lastly, administration of an insulin toler-
ance test on miR-184 transgenic mice (dox-184) that overex-
press miR-184 in a doxycycline-inducible manner revealed no
changes compared with littermate controls indicating in-
creased expression of this miRNA does not significantly con-
tribute to systemic insulin sensitivity (Fig. 2M). Together, our
results indicate that it is the regulation of this miRNA in
response to changes in energy metabolism that is conserved
from mice to flies.
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miR-184 Is Regulated upon Inhibition of GlucoseMetabolism
by Tunicamycin—To further test whether inhibition of glucose
metabolism by other mechanisms can impact the expression of
miR-184 and its targets, we treated MIN6 cells with the
N-linked glycosylation blocker, tunicamycin (25). At all con-
centrations of a dose-response curve, miR-184 expression was
significantly increased compared with vehicle alone, as was the
expression of the endoplasmic reticulum stress-related genes,
C/ebp and Chop (Fig. 3, A and E). Again consistent with Ago2
and Slc25a22 being targeted by miR-184, the target gene
expression decreased after administration of tunicamycin com-
pared with vehicle alone (Fig. 3B), whereas the expression of
Ago1 and other miRNAs includingmiR-375 and let-7c did not
change (Fig. 3, C andD). The robustness of the inverse correla-
tion between miR-184 and its target Ago2 in response to
changes in glucose metabolism suggests an important role for
these genes in the maintenance of -cell function. Although
treatment of the MIN6 cells with palmitic acid also induced
expression of endoplasmic reticulum stress-related genes, nei-
thermiR-184 nor Ago2 levels were affected, further supporting
the effect of glucose metabolism on their expression (Fig. 3F).
Together, these results strongly implicate the regulation of
miR-184 and its targets according to glucose metabolism.
miR-184 Regulates the -Cell Secretome—We further ad-
dressed the impact of miR-184 on -cell function by quantify-
ing the secreted proteins after overexpression of this miRNA.
SILAC-labeled MIN6 cells that were transfected withmiR-184
mimics exhibited a reduced capacity to secrete the previously
identified cluster of proteins upon receiving high glucose (Fig.
4A and supplemental Table S1) (26). Importantly, a significant
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FIGURE 1. miR-184 is regulated according to glucose metabolism. A, qRT-PCR analysis of relative miR-184 expression in isolated pancreatic islets (Isl),
pituitary (Pit), adrenal gland (Adr), and thyroid (Thy) from 10-week-old C57BL/6 mice. AU, arbitrary units. B, qRT-PCR analysis of relativemiR-184 expression in
several pancreatic cell lines including MIN6, Panc1, DanG, and MiaPaca. C, qRT-PCR analysis of miR-184 in isolated islets of 10-week-old WT mice on either a
normal chow (Ch) or ketogenic (Keto) diet for 75 days (n 4). Randombloodglucose levelswere decreased after 1 day on ketogenic diet. Results are presented
as mean  S.E. *, p  0.05; **, p  0.01; ***, p  0.001. D, qRT-PCR analysis of miR-184 in isolated islets of 10-week-old WT mice on either normal chow or
ketogenic diets for 25 days. Mice on the ketogenic diet were reverted to normal chow for 0–48 h (n 4). n.s., not significant. E, blood glucose levels during a
glucose tolerance test (GTT) from 10-week-old C57BL/6 mice on normal chow (Chow), ketogenic diet (Keto), and normal chow after 25 days on ketogenic diet
(Keto re-feed) (n 4). F, blood glucose levels during an insulin tolerance test (ITT) from 10-week-old C57BL/6 mice on normal chow (Chow), ketogenic diet
(Keto), and normal chow after 25 days on ketogenic diet (Keto re-feed) (n 4). G, qRT-PCR analysis ofmiR-184 andmiR-375 in isolated islets of 10 weeks old
WTmice fasted for 24 h. Fed and fasted blood glucose and insulin parameters measured before sacrifice (n 4). H, qRT-PCR analysis ofmiR-184 andmiR-375
after treatingMIN6 cells with either 100 nM insulin or 20 nM of exendin-4 (Ex4) for 48 h (n 3–4). I, qRT-PCR analysis ofmiR-184 in isolated islets of 10-week-old
WT mice on either normal chow or a low calorie diet for 25 days (n 4). J, qRT-PCR analysis of miR-184 in Drosophila after sucrose administration and after
fasting and re-feeding. After a 16 h starvation period, flies were fed with food in which the only caloric supplement is sucrose (5%). Fly heads were collected
from flies re-fed for 0, 6, 12, and 18 h of sugar administration.
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overlap was observed after treatment with miR-184 mimics
comparedwith previous secretome profiles that were identified
after high glucose treatment or siRNA-mediated inhibition of
glucokinase (Fig. 4, B–D) (26). These observations are consis-
tent with previous results after overexpression of miR-375,
indicating several miRNAs may coordinately contribute to the
mechanisms leading up to the release of insulin by the -cell
and not to the composition of insulin-containing granules (26).
As none of the proteins identified as a part of the secretome is
predicted as direct targets ofmiR-184, these resultsmay suggest
abundant miRNAs may impact glucose sensing, mitochondrial
metabolism or localization, ion channel function, or the
recruitment or fusion of vesicles to the plasma membrane.
miR-184 Regulates Mitochondrial Respiration—We previ-
ously identified the mitochondrial gene Slc25a22 as a target of
miR-184 and, therefore, investigated the effect of this miRNA
on cellular respiration (13). Transfection ofmiR-184mimics in
MIN6 cells resulted in a significant decrease of mitochondrial
coupling efficiency, and this reduction was caused by reduced
glucose-stimulated cellular respiration and not altered mito-
chondrial proton leak (Fig. 5,A and B). Because the basal respi-
ration remained unchanged, these observations indicate that
miR-184 regulates secretion via mitochondrial substrate flux in
the -cell, possibly by suppressing validated targets such as
Slc25a22 at the mitochondria (Fig. 5, C and D) (13). Further-
more, transmission electron microscopic analysis of the islets
isolated from dox-184mice revealed a number of morphologi-
cal alterations including disruption of the lamellae within the
mitochondria (Fig. 5, E and F) (13). Previous studies have asso-
ciated these changes with the loss of cytochrome c-4CYS and
mitochondrial function (27). Additionally, a small reduction in
the number of mitochondria per cell was observed in dox-184
-cells (p  0.10, quantified from transmission electron micros-
copy images at 8000magnification:mean (WT) 22.5mitochon-
dria/cell; mean (dox-184) 18.5 mitochondria/cell; 25 cells from
each set pooled from n 3 mice). Together these results suggest
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that miR-184 may impact the -cell secretome by targeting
Slc25a22 and ultimately mitochondrial respiration.
Ago2 Is Localized at the Mitochondria in MIN6 Cells—As
recent studies have established a role for Ago2 within themito-
chondria (28), we next examined the localization of Ago2 in
MIN6 cells. Ago2 was found abundant in eluted fractions inde-
pendent of the insulin peak and the granule markers Nsf and
Rab3a, suggesting it is not enriched at the secretory granules
(Fig. 6A). Western blotting identified Ago2, Slc25a22, and
Bcl-xL were present in the mitochondria-containing fractions
after subcellular purification (29, 30) (Fig. 6B). siRNA-mediated
knockdownofAgo2 inMIN6 cells further confirmed its expres-
sion in both the cytoplasmic and mitochondrial fractions (Fig.
6C). These data suggest that miR-184 may impact the growth
and function of the -cell by targeting genes present at the
mitochondria including Ago2 and Slc25a22.
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Restoration of Ago2 in the Presence of miR-184 Maintains
Normal Glucose Homeostasis—To investigate the impact of
altering expression ofmiR-184 on the -cell transcriptome, we
performed gene expression analysis using Illumina mouse
W2vG arrays. The murine MIN6 -cell line was transfected
with two plasmids expressing 1) the reverse tetracycline trans-
activator (rtTA) and 2) a genomic fragment encompassing the
miR-184 precursor under the control of the tet operon (184-
tetO). Upon treating the cells with 1 g/ml doxycycline (dox),
we observed a progressive increase ofmiR-184 after 16 h of dox
administration, whereas genes containing miR-184-seed
matches significantly decreased their expression compared
with genes without seed matches (Fig. 7, A and B). The down-
regulation of miR-184 targets was transient over time, in line
with miR-184 targeting Ago2. In addition, genes containing
matches for the seeds of three additional miRNAs that are
abundant in this cell line including miR-375, 182, 30a, and
148a/152, were progressively up-regulated compared with
genes without seed matches for these miRNAs, consistent with
the idea thatmiR-184 can impact miRNA-mediated regulation
via the down-regulation of Ago2 (Fig. 7A).
To further test the physiologic relevance of the targeting of
Ago2 by miR-184, we next crossed two previously generated
transgenic mouse models that allowed overexpression of Ago2
andmiR-184 in the pancreatic-cell in a doxycycline-inducible
manner (dox-Ago2 and dox-184, respectively) (13). Doxycy-
cline-dependent Ago2 expression was possible in the presence
of miR-184 in dox-184/Ago2 animals as the Ago2 transgene
lacked the 3-UTR harboring themiR-184-seed sequence (13).
Dox-184/Ago2 mice exhibited comparable expression of both
miR-184 and Ago2 to their littermate controls, dox-184 and
dox-Ago2, respectively (Fig. 7, C and D). Although dox-Ago2
mice displayed normal random glucose and glucose tolerance
after treatment of doxycycline, dox-184 animals were hypergly-
cemic as a result of decreased circulating insulin as previously
shown (Fig. 7, E–G) (13). Interestingly, dox-184/Ago2 mice
maintained normal steady-state glucose and insulin levels and
glucose tolerance in contrast to dox-184 mice, indicating that
the maintenance of Ago2 expression in the presence of miR-
184 restored normal glucose control (Fig. 7, F–H). Further-
more, pancreatic -cell mass and proliferation rate were also
restored in dox-184/Ago2 mice consistent with the mainte-
nance of glucose homeostasis in these animals (Fig. 7, I and J)
(13). To determine whether the capacity to maintain miRNA-
mediated gene regulation by Ago2 remained intact in dox-184/
Ago2 mice, we next assessed the expression of miR-375-tar-
geted genes in isolated islets. Expression of Cadm1, Gphn, and
Rasd1was lower in islets isolated from dox-184/Ago2mice and
islets of dox-Ago2 animals compared with littermate controls
(Fig. 7K). Although the mechanism of this rescue is not pre-
cisely clear, these results show Ago2-mediated gene regulation
is maintained in these animals andmay indicate the function of
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other abundant miRNAs including miR-375 countering the
action of miR-184. To determine whether overexpression of
miR-184 leads to de-differentiation of the -cell, a broad range
of islet marker genes was quantified by qRT-PCR (Fig. 7L).
Although marked increases in Ngn3, Ppy, and Gck were
observed in islets from dox-184 mice, suggesting a degree of
de-differentiation, the majority of genes remained unchanged,
indicating miR-184 is not a significant contributor to -cell
differentiation (Fig. 7L).
Discussion
Animals adapt their physiology to changes in nutrient intake
through specific molecular mechanisms. Interestingly, organ-
isms at all levels of complexity display increased longevity in
response to caloric restriction, suggesting that the fundamental
components of these pathways is highly conserved (31, 32).
During fasting conditions, it has long been known that the pan-
creatic-cell reduces its output of secreted insulin, indicating a
central role for glucosemetabolism in-cell physiology (1).We
recently showed that miR-184, a highly conserved and abun-
dant miRNA expressed in the -cell, regulates compensatory
proliferation and secretion during insulin resistance (13). In
contrast to all othermiRNAs that are expressed in this cell type,
miR-184was silencedwith the onset insulin resistance and then
re-emerged upon administration of a low carbohydrate, keto-
genic diet. These observations, after administration of either
high fat or ketogenic diets, implicate changes in nutrient intake
and insulin sensitivity in the regulation of this miRNA.
Here in this study we follow up on these observations to
address the specific impact of nutrient metabolism on the
miRNApathway and show that expression of bothmiR-184 and
its targetAgo2 are sensitive to changes in glucosemetabolism in
the -cell. Although miR-184 levels in mouse islets increased
after a ketogenic diet, the levels of this miRNA were restored
within 24 h after reversion to a normal chow diet. In contrast,
placingmice on a high fat diet required several weeks for induc-
ing the silencing of this miRNA (13). These results suggest that
the -cell may respond more acutely to specific stimuli such as
glucose than to changes in insulin sensitivity. Although the
knockouts of miR-184 and Ago2 in the -cell both exhibit no
changes during an insulin tolerance test, these results indicate
the miRNA pathway in this cell type may not significantly con-
tribute to systemic insulin sensitivity (13, 18). The functional
link between miR-184 and glucose metabolism in the -cell is
further supported by the relatively specific expression profile of
this miRNA. In contrast to other abundant miRNAs in the
-cell such as miR-375, miR-184 does not appear to be
expressed in the pituitary, adrenal gland, or exocrine pancreas.
This limited expression profilemay highlight the importance of
this miRNA in the regulation of -cell function according to
changes in energy homeostasis.
Importantly, it has long been known that haploinsufficiency
of Gck resulted in decreased insulin release, underlining the
essential role of glucose sensing and metabolism in mediating
secretion by the -cell (33). Our observation that the knock-
down of glucokinase resulted in increased expression of miR-
184 indicates that the -cells activate the expression of this
miRNA to suppress insulin release when either glucose sensing
or glycolysis is attenuated. Both 2-deoxyglucose and tunicamy-
cin treatments had similar effects, further underlining the role
of glucose metabolism in the regulation of miR-184. Impor-
tantly, although both of these reagents are also widely known to
induce endoplasmic reticulum stress and the unfolded protein
response, the absence of any effect of palmitic acid suggests that
the endoplasmic reticulum stress pathway does not signifi-
cantly contribute to changes inmiR-184 expression (34).
The precise role of the miRNA pathway remains to be estab-
lished; however, a recurring theme inmany published studies is
its function in adaptive stress responses (14). In light of the
robust inverse correlation between miR-184 and Argonaute2
expression, our observations from the dox-184/Ago2 mice
C
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would also suggest that many aspects of the involvement of
these two genes in glucose homeostasis remain to be described.
It is unclear whether the normoglycemia and glucose tolerance
observed in these mice results from Ago2-mediated gene
silencing or a non-canonical effect of Ago2 on gene expression
via its localization in the nucleus, mitochondria, or stress gran-
ule of the -cell (28, 35, 36). Nonetheless, the restoration of
normal glucose homeostasis and -cell mass in the dox-184/
Ago2model provides further support for Ago2 as a biologically
relevant target ofmiR-184 using an in vivo system.
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Although our results continue to underline miR-184 as a
potent inhibitor of insulin release, the precise actions of its
identified targets remain unclear (13, 26). Inhibition of the two
validated targets of this miRNA, Ago2 and Slc25a22, result in
contradictory effects on glucose-stimulated insulin secretion
and may suggest a hierarchical presence among targets.
Although miR-184 expression is elevated as glucose metabo-
lism is attenuated in the -cell, it is possible the suppression of
Slc25a22 under these conditions may have a more appreciable
effect than the suppression of Ago2 in the absence of any glu-
cose stimulus. Conversely, we observed the silencing of miR-
184 in the presence of high extracellular glucose concentra-
tions. Although increased expression of both Ago2 and miR-
375 will contribute to suppress secretion, these genes mediate
compensatory proliferation asmetabolic demand increases and
may highlight another functional hierarchy within this cell type
(13, 18). In light of the proliferative effect of glucose on the
-cell, our results continue to indicate the miRNA pathway
facilitates growth and in turn compromises insulin release. It is
possible that as the need for insulin rises, proliferation is prior-
itized and the suppression of secretion is ultimately inconse-
quential as more cells are present to alleviate metabolic
demand. Importantly, it remains to be precisely described how
the -cell mediates the energy balance between cell size and
growth, granule synthesis, and insulin release.
Interestingly, recent studies have shown Ago2 may complex
miRNAs independent of target mRNAs according tometabolic
state (38). Future studiesmay identify themajority if not the full
extent of -cell transcripts critical to the regulation of its
growth and function complexed to miRNAs and RNA-binding
proteins such as Ago2 largely during periods of increased met-
abolic demand such as the post-prandial state. The occupancy
of these-cell genes by RNA-protein complexesmay in turn be
determined bymetabolic cues such as shifts in systemic glucose
levels (39). The presence ofmiRNAs andRNA-binding proteins
on these-cell genesmay act to “stall” their expression until the
demand ceases, at which time miRNAs and associated binding
proteins are “de-recruited” to an inactive and uncomplexed
state. The miRNA pathway may ultimately act as an energy-
efficient means of modulating gene expression according to
changes in metabolic demand rather than solely implementing
de novo transcription to promote expression or degradation of
critical mRNAs to silence genes.
As miR-184 is highly conserved, future studies may also
address how this miRNA impacts energy homeostasis in other
model organisms includingAplysia andDrosophila to decipher
the most fundamental aspects glucose metabolism (22).
Although progress is currently hindered due in part to the
absence of accurate annotations of orthologous genes between
Drosophila andmammalian species, several key components of
the insulin/Igf-like signaling (IIS) pathway are conserved. In
addition, the transcription factor dFOXO has been implicated
in metabolic processes in many organisms; however, the extent
to which its function is conserved between species remains
unclear (37). Likewise, Ago1 is the established mediator of
miRNA-mediated gene regulation in Drosophila species, fur-
ther suggesting that although the functional role of miR-184
may be conserved between species, the transcription factors
promoting its expression as well as its direct targetsmay not be.
Future studies emphasizing the identification of the key fac-
tors regulating energy homeostasis, which are conserved
between species, will have strong implications on the study of
longevity and metabolic disease. Our results shown using Dro-
sophilamay play a key role in elucidating the fundamental rela-
tionship between miR-184 and energy homeostasis and how
these genes can impact the aging process or the onset of insulin
resistance and diabetes.
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